§ Funding Round
Series B funding round for Passage Bio raising $110M in September 2019
Series B funding round for Passage Bio raising $110M in September 2019
| Investor | Firm Type | Partner |
|---|---|---|
Access BiotechnologyLEAD | — | — |
| Organization | — | |
| Organization | — | |
Domain Associates | — | — |
| Organization | — | |
| Organization | — | |
InterWest | — | — |
| Organization | — | |
| Organization | — | |
SV Health Investors | — | — |
Wildcat Ventures | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Logos Capital | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$230M
Top Valuation
-
Passage Bio raised $110M in a Series B round.
The round was announced on 09/01/19.
The round was led by Access Biotechnology.
